Rozerem Tablets 8mg drug use surveillance: Survey on insomnia associated with sleep-onset difficulty
Not Applicable
- Conditions
- Insomnia
- Registration Number
- JPRN-jRCT1080222309
- Lead Sponsor
- TAKEDA PHARMACEUTICAL COMPANY LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Sleep-onset difficulty associated with insomnia
Exclusion Criteria
1. Patients with previous history of hypersensitivity to an ingredient of Rozerem Tablets
2. Patients with severe liver dysfunction
3. Patients taking fluvoxamine maleate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method